- Cellectis dévoile dans Nature Communications de nouvelles cellules CAR T universelles immuno-évasives dotées d'une persistance potentiellement améliorée
- Cellectis Publishes Article in Nature Communications Unveiling Novel Immune-Evasive Universal Allogeneic CAR T-cells with Potential for Improved Persistence
- Cellectis annonce les nominations d'Axel-Sven Malkomes et de Donald A Bergstrom, M.D., Ph.D. à son conseil d'administration
- Cellectis Announces the Appointment of Axel-Sven Malkomes & Dr. Donald A Bergstrom, M.D., Ph.D., to its Board of Directors
- Résultats de l’Assemblée Générale Mixte des Actionnaires de Cellectis S.A. du 28 juin 2022
- Cellectis S.A. Reports Results from Annual Shareholders’ General Meeting Held on June 28, 2022
- Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
- Monthly information on share capital and company voting rights
- Cellectis’ Annual Shareholders’ General Meeting to be Held on June 28, 2022
- L’Assemblée Générale Mixte de Cellectis se tiendra le 28 juin 2022
More ▼
Key statistics
On Friday, Cellectis SA (ALCLS:PAR) closed at 2.66, 22.26% above the 52 week low of 2.17 set on Jun 16, 2022.
52-week range
Markit short selling activity
Open | 2.72 |
---|---|
High | 2.80 |
Low | 2.64 |
Bid | 2.64 |
Offer | 2.74 |
Previous close | 2.65 |
Average volume | 284.79k |
---|---|
Shares outstanding | 45.48m |
Free float | 38.34m |
P/E (TTM) | -- |
Market cap | 121.50m EUR |
EPS (TTM) | -2.85 EUR |
Data delayed at least 15 minutes, as of Jul 01 2022 16:35 BST.
More ▼